Aivita Launches Phase 2 Trial of Dendritic Cell Immunotherapy for Ovarian Cancer – Ovarian Cancer News Today
Ovarian Cancer News Today |
Aivita Launches Phase 2 Trial of Dendritic Cell Immunotherapy for Ovarian Cancer
Ovarian Cancer News Today Aivita Biomedical has initiated a Phase 2 trial of a new kind of dendritic cell immunotherapy for certain types of ovarian cancer. The therapy uses a patient's own dendritic cells, which are boosted to fight the tumor by exposure to tumor proteins. The … |
